Management of cardiogenic shock complicating myocardial infarction: an update 2019

Area of Science:

• Cardiology
• Critical Care Medicine

Background:

• Cardiogenic shock (CS) is the leading cause of mortality in acute myocardial infarction (AMI) patients.
• Despite advances, CS mortality remains high at 40-50% over the past two decades.
• Current management includes revascularization, vasopressors, inotropes, fluids, and mechanical support, but evidence is limited.

Purpose of the Study:

• To provide an updated review on the management of cardiogenic shock complicating AMI.
• To highlight state-of-the-art treatment strategies based on current evidence.

Main Methods:

• Literature review of current management strategies for CS in AMI.
• Focus on evidence supporting different treatment modalities.

Main Results:

• Early revascularization is a key treatment for CS in AMI.
• Evidence for other interventions like vasopressors, inotropes, and fluids is limited.
• Intra-aortic balloon pumping shows limited effectiveness.

Conclusions:

• Effective management of CS in AMI requires a comprehensive approach.
• Further research is needed to establish robust evidence for various treatment strategies.
• State-of-the-art care focuses on timely revascularization and tailored supportive therapies.